(Reuters) -Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster ...

Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...

Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to all product orders shipped to the U.S.

Millipore’s gene therapy production efforts began in 1997, predating its acquisition by Merck KGaA by 13 years. In 2021, the companies expanded their gene therapy production campus in Carlsbad ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma's new chronic ...

Merck said last week its biggest tariff exposure is through Keytruda and it has enough US inventory for this year. It estimated $200 million in additional costs for the levies implemented to date.

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance ...

Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing. The move comes amid plans by President Trump to impose tariffs on ...

Date range: 1 August 2023 - 31 July 2024 No articles found. Merck Millipore Saint-Quentin-en-Yvelines did not contribute to any primary research papers from Nature Index journals in the current 12 ...

Insurers for Merck & Co. must help cover losses from a $1.4 billion cyberattack that the U.S. blamed on Russia, a court said, rejecting the insurers’ argument that the attack was akin to an act ...